Skip to navigation Skip to content

Research Study: Role of the Gut Microbiome in Depression in MS

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: NA
Number of Subjects: 120
Medication: NA
Location: Missouri
Institutions: Washington University in St. Louis Contact Information
Courtney Dula
314-362-3402
dulac@wustl.edu

Funding:

NA

Description

Investigators at Washington University in St. Louis are conducting a research study for people with multiple sclerosis (MS). The purpose of this study is to determine the potential effects of the gut microbiome on depression in MS. They are enrolling individuals with MS (including those with relapsing-remitting MS in remission or with progressive disease), who have been clinically stable for at least 3 months and are either untreated or on disease-modifying therapy.

As a voluntary participant, you will be asked to spend up to 2 hours during a one-time, in-person study visit. During this visit, you will be asked questions about your MS history, undergo neurological assessments (including a neurological exam, the MS functional composite, and cognitive screening tests), complete study questionnaires, and have blood drawn.
Participants will be compensated.

If this is of interest to you, please contact Courtney Dula to get started with surveys. Her email is dulac@wustl.edu and her phone number is 314-362-3402.

Please note: This is not a clinical trial of an intervention, but rather a research study.

Share


© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.